Schedule 2 medicine – is it over the counter?
What Schedule 2 means in South Africa, why the pharmacist still matters, and how to check whether a particular product needs a prescription.
Schedule 2 means pharmacy control, not a blanket yes or no
A Schedule 2 medicine is controlled through pharmacy supply in South Africa. That does not mean every Schedule 2 product is automatically appropriate for self-treatment or that every pack follows the same practical process. The pharmacist checks the exact product, the reason for using it and the person taking it.
What the pharmacist is checking
- The ingredient, strength, form and pack size.
- Age, pregnancy or breastfeeding, allergies and important medical conditions.
- Other prescription, pharmacy, traditional or complementary products.
- Whether the symptom needs a clinician rather than a repeat purchase.
A Schedule 2 label is not a dosing instruction. Use the exact label or leaflet and ask when the wording is unclear.
Before you take it
- Take the box or a clear photo of the label to the pharmacist.
- Explain the symptom, when it started and what you have already tried.
- Show your current medicine list, including traditional remedies and supplements.
- Check the maximum duration of self-care and the warning signs that need a clinic.
Do not let the schedule delay urgent care
Common questions
- Can you get Schedule 2 medicine without a prescription?
- Some Schedule 2 medicines may be supplied through a pharmacy without a doctor's prescription, but the exact product and conditions decide. Ask the pharmacist rather than assuming.
- Is Schedule 2 safer than Schedule 3?
- The number describes legal control and supply conditions, not a simple personal safety ranking. Any medicine can be harmful when it is wrong for the person or used incorrectly.
Sources
- Medicines and Related Substances Act 101 of 1965, and SAHPRA scheduling guidanceSouth African Health Products Regulatory Authority
- Medicines Online Directory and approved patient information leafletsSouth African Health Products Regulatory Authority
Last reviewed 26 August 2026.